CLINICAL_TRIALS
trial_result
· 2018-10-25
Clinical Trial Update: Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder [Phase 2]
Summary
Phase 2 trial update for SPD489 in preschool children with ADHD reports on safety, tolerability, pharmacokinetics, and efficacy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Attention Deficit Hyperactivity Disorder (ADHD) | Phase 2 | Status: COMPLETED | Results posted: 2018-10-25